Drug Standards
![Medchemexpress LLC 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1) | 161796-78-7 | MFCD00870347 | 99.4% | 367.40 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000384294-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1) | 161796-78-7 | MFCD00870347 | 99.4% | 367.40 | 5 MG
Esomeprazole sodium is a potent and orally active proton pump inhibitor. It reduces acid secretion by inhibiting the H+, K+-ATPase in gastric parietal cells. Additionally, it acts as an exosome inhibitor by blocking exosome release through the inhibition of V-H+-ATPases. It has potential for research related to symptomatic gastroesophageal reflux disease and for suppressing the growth of triple-negative breast cancer cells.
- Potent and orally active proton pump inhibitor
- Reduces acid secretion
- Acts as an exosome inhibitor
- Potential for symptomatic gastroesophageal reflux disease research
- For research use only
Medchemexpress LLC Abacavir | 136470-78-5 | CB5698138 | 99.0% | 286.34 | 100 MG
Abacavir is an orally active and competitive nucleoside reverse transcriptase inhibitor. It can inhibit the replication of HIV and shows anticancer activity in prostate cancer cell lines. Abacavir is capable of trespassing the blood-brain-barrier and suppressing telomerase activity.
- Inhibits HIV replication
- Exhibits anticancer activity in prostate cancer cell lines
- Crosses the blood-brain-barrier
- Suppresses telomerase activity
- Induces fat apoptosis
- Inhibits cell growth and affects cell cycle progression in prostate cancer cell lines
- Reduces cell migration and inhibits cell invasion
Medchemexpress LLC Keto Ziprasidone | 884305-07-1 | MFCD30747855 | 99.0% | 426.92 | C21H19ClN4O2S | 5 MG
Keto Ziprasidone is a characterized impurity of the antipsychotic ziprasidone supplied for research use only. It is provided as a solid reference standard for analytical, identification, and investigational studies involving serotonin and dopamine receptor antagonists.
- Provides a characterized impurity standard for analytical and identification work.
- CAS number 884305-07-1.
- Molecular formula C21H19ClN4O2S; molecular weight 426.92.
- Purity 98.96% suitable for research applications.
- Solid, off-white to light yellow appearance.
- Storage: powder at -20°C; in solvent at -80°C (6 months) or -20°C (1 month).
- Available in small milligram pack sizes for reference use.
Sigma Aldrich Fine Chemicals Biosciences Phytol >=97%, FG | 7541-49-3 | MFCD00002919 | 1KG
Phytol >=97%, FG | Purity: >=97% | Mol Wt: 296.53 | 7541-49-3 | MFCD00002919 | 1KG
Apexbio Technology LLC Haloperidol 52-86-8 10mM (in 1mL DMSO)
Haloperidol is a small-molecule antagonist targeting dopamine receptors It is designed to block dopamine signaling thereby modulating neurotransmission within cortical limbic and nigrostriatal pathways Haloperidol exerts its biological activity primarily through inverse agonism at dopamine receptors Based on these pharmacological properties Haloperidol holds research potential in psychiatric and neuropsychological applications including studies of delirium delusions hallucinations and characterization of dopamine-mediated neuronal circuits and behavioral models in psychiatric disorders
Apexbio Technology LLC MEK162 (ARRY-162, ARRY-438162) 606143-89-9 50mg
MEK162 (ARRY-162 ARRY-438162 CAS 606143-89-9) is a selective inhibitor of MEK1 and MEK2 kinases exhibiting an IC50 of approximately 12 nM By targeting the MAPK/ERK signaling pathway MEK162 inhibits ERK1/2 phosphorylation reduces clonal survival and induces apoptosis in melanoma cell models including those harboring N-RAS GNAQ or GNA11 mutations Studies also indicate that combining MEK162 with PKC inhibitors leads to sustained suppression of MAPK signaling and enhanced pro-apoptotic effects in uveal melanoma cells Early-phase clinical research has reported transient typically mild retinopathy associated with MEK162 treatment This compound is widely utilized in studies of targeted melanoma therapies
![Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]- | 51384-51-1 | 99.9% | 267.36 | 10 MM / 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000387184-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]- | 51384-51-1 | 99.9% | 267.36 | 10 MM / 1 ML
Metoprolol is an orally active, selective β1-adrenoceptor antagonist. It exhibits anti-inflammatory, antitumor, and anti-angiogenic properties.
- Orally active
- Functions as a selective β1-adrenoceptor antagonist
- Shows anti-inflammatory effects
- Exhibits antitumor properties
- Demonstrates anti-angiogenic characteristics
Medchemexpress LLC Metoprolol succinate | 98418-47-4 | 99.6% | 652.82 | 200 MG
Metoprolol succinate is an orally active, selective β1-adrenoceptor antagonist. It shows anti-inflammation, antitumor and anti-angiogenic properties.
- Exhibits cytotoxic effects on U937 and MOLT-4 cells.
- Reduces proinflammatory cytokines and atherosclerosis in ApoE-/- Mice.
- Demonstrates anti-inflammation and anti-virus effects in murine model with coxsackievirus B3-induced viral myocarditis.
- Decreases activated caspase-9 protein expression.
- Inhibits myocardial apoptosis.
Sigma Aldrich Fine Chemicals Biosciences Methotrexate impurity E European Pharmacopoeia (EP) Reference Standard | 19741-14-1 |
Methotrexate impurity E European Pharmacopoeia (EP) Reference Standard | Mol Wt: 324.32 | 19741-14-1 |